William Ho - 13 Nov 2024 Form 4 Insider Report for RAPT Therapeutics, Inc. (RAPT)

Reporting relationship
CHIEF MEDICAL OFFICER
Issuer ticker
RAPT
Reported as of
13 Nov 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
15 Nov 2024, 20:00:15 UTC
Prior SEC filing
01 Feb 2024
Next SEC filing
03 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Rodney Young, Attorney-in-Fact

Key filing fact

William Ho filed Form 4 for RAPT Therapeutics, Inc. (RAPT) on 15 Nov 2024.

Key facts

  • This page summarizes William Ho's Form 4 filing for RAPT Therapeutics, Inc. (RAPT).
  • 12 reported transactions and 12 derivative rows are listed below.
  • Accepted by SEC: 15 Nov 2024, 20:00.

Change

  • Previous filing in this sequence was filed on 01 Feb 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RAPT transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-7,807
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,807
Exercise price
$12.00
Footnotes
F1
RAPT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+7,807
Change %
Price
$0.000000
Shares after
7,807
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
7,807
Exercise price
$1.57
Footnotes
F1
RAPT transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-20,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$44.66
Footnotes
F2, F3
RAPT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+20,000
Change %
Price
$0.000000
Shares after
20,000
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
20,000
Exercise price
$1.57
Footnotes
F2, F3
RAPT transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-55,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
55,000
Exercise price
$19.53
Footnotes
F4, F5
RAPT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+55,000
Change %
Price
$0.000000
Shares after
55,000
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
55,000
Exercise price
$1.57
Footnotes
F4, F5
RAPT transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-55,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
55,000
Exercise price
$19.86
Footnotes
F6, F7
RAPT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+55,000
Change %
Price
$0.000000
Shares after
55,000
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
55,000
Exercise price
$1.57
Footnotes
F6, F7
RAPT transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-56,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
56,000
Exercise price
$29.05
Footnotes
F8, F9
RAPT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+56,000
Change %
Price
$0.000000
Shares after
56,000
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
56,000
Exercise price
$1.57
Footnotes
F8, F9
RAPT transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-75,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
75,000
Exercise price
$24.75
Footnotes
F10, F11
RAPT transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+75,000
Change %
Price
$0.000000
Shares after
75,000
Date
13 Nov 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
75,000
Exercise price
$1.57
Footnotes
F10, F11
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 11 footnotes

Footnote F1

The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on October 30, 2019 for 22,083 shares and is fully vested.

Footnote F2

The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 30, 2020.

Footnote F3

1/48th of the shares subject to the option vested or shall shall vest on each monthly anniversary of the vesting start date of January 1, 2020.

Footnote F4

The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2021.

Footnote F5

1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2021.

Footnote F6

The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 28, 2022.

Footnote F7

1/48th of the shares subject to the option vested or shall vest on each monthly anniversary of the vesting commencement date of January 1, 2022.

Footnote F8

The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2023.

Footnote F9

1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2023.

Footnote F10

The two reported transactions involved an amendment of an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on January 31, 2024.

Footnote F11

1/48th of the shares subject to the option shall vest on each monthly anniversary of the vesting commencement date of January 1, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .